FIA
MED icon

FNY Investment Advisers’s Medifast MED Stock Holding History

FNY Investment Advisers’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-15
Closed -$1K – 842
2018
Q4 		$1K Hold
15
– – ﹤0.01% 617
2018
Q3 		$3K Buy
+15
New +$3.04K ﹤0.01% 674

Other funds holding MED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

FNY Investment Advisers's MED Position: Q2 2020 in Review

FNY Investment Advisers sold out of Medifast (MED) in Q2 2020, closing a stake of 2,730 shares — an estimated $170K sold.

FNY Investment Advisers first reported a position in MED in Q2 2018 and held it in 3 quarters. The position peaked at $187K in Q4 2018. 224 funds tracked by Wall St. Rank hold MED as of Q2 2020.

  • FNY Investment Advisers reported no remaining Medifast position as of Q2 2020 after selling out during the quarter.
  • FNY Investment Advisers sold 2,730 Medifast shares in Q2 2020, an estimated $170K.
  • FNY Investment Advisers first reported a position in Medifast in Q2 2018 and held it in 3 quarters.
  • FNY Investment Advisers's Medifast position peaked at $187K in Q4 2018.
  • 224 funds tracked by Wall St. Rank held Medifast as of Q2 2020.

Based on FNY Investment Advisers's 13F filing for Q2 2020, filed 10 Jul 2020.